Zenith Drugs Limited (NSE:ZENITHDRUG)
47.00
-1.70 (-3.49%)
Jan 23, 2026, 3:19 PM IST
Zenith Drugs Revenue
Zenith Drugs had revenue of 782.24M INR in the half year ending September 30, 2025. This brings the company's revenue in the last twelve months to 1.44B, up 10.01% year-over-year. In the fiscal year ending March 31, 2025, Zenith Drugs had annual revenue of 1.33B with 1.29% growth.
Revenue (ttm)
1.44B
Revenue Growth
+10.01%
P/S Ratio
0.58
Revenue / Employee
7.90M
Employees
182
Market Cap
835.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.33B | 17.00M | 1.29% |
| Mar 31, 2024 | 1.32B | 171.01M | 14.93% |
| Mar 31, 2023 | 1.15B | 228.64M | 24.95% |
| Mar 31, 2022 | 916.55M | 182.53M | 24.87% |
| Mar 31, 2021 | 734.02M | -48.67M | -6.22% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bal Pharma | 2.95B |
| Mangalam Drugs & Organics | 2.38B |
| Makers Laboratories | 1.31B |
| Godavari Drugs | 1.06B |
| Accretion Pharmaceuticals | 826.43M |
| Mercury Laboratories | 773.75M |
| Source Natural Foods and Herbal Supplements | 555.64M |
| Concord Drugs | 450.74M |